Susan Hopkins
banner
smhopkins.bsky.social
Susan Hopkins
@smhopkins.bsky.social
CEO, UKHSA

Infectious diseases clinician and epidemiologist

Hon Consultant Infectious Diseases, Royal Free London
Hon Prof Infectious Diseases & Health Security, UCL
Reposted by Susan Hopkins
H3N2 subclade K dominating early flu season in UK. Emerged at end of the southern hemisphere flu season, varies from the J.2 subclade chosen for this year’s vaccination. Current vaccine still thought to offer protection so…

Get your flu Vax! #IDSky #vaccines

www.gavi.org/vaccineswork...
Everything you need to know about ‘subclade K’ flu - and vaccine protection against it
As a new branch of H3N2 influenza gains ground, we explore what it means for this season’s flu vaccine.
www.gavi.org
November 15, 2025 at 2:37 AM
Reposted by Susan Hopkins
Partner notification is a key part of STI care but uptake in many LMIC settings is low.

Our RCT in Zimbabwe tried to improve uptake via financial incentives.

Results out in Lancet Global Health.

tl;dr Answer was no. Possibly as incentive only averted indirect costs of care & that wasn't enough.
Financial incentives to improve uptake of partner treatment for sexually transmitted infections in antenatal care: a cluster randomised trial in Zimbabwe
Financial incentives did not address barriers to index participants informing partners, and ultimately did not improve partner attendance for STI treatment. Multifaceted packages addressing barriers f...
www.thelancet.com
November 13, 2025 at 8:03 AM
Reposted by Susan Hopkins
Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratification

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WbLI1G
September 28, 2025 at 7:17 PM
Reposted by Susan Hopkins
🆕 New in ICHE: How did the COVID-19 pandemic impact HAIs and AMR in Canadian hospitals?

📈 This interrupted time series study (2018–2022) found significant increase in HAIs and AMR organisms following the onset of the pandemic

#IDSky

📄: doi.org/10.1017/ice....
September 18, 2025 at 2:09 PM
Reposted by Susan Hopkins
“Fast change, little spread”

The University of Oxford’s Prof Katrina Lythgoe and Dr. Mahan Ghafari unpack ONS-CIS data on 576 persistent infections, rapid within-host evolution, and rare transmission after 1 month. #IDsky #MEDsky

Read our Q&A: www.contagionlive.com/view/persist...
Persistent SARS-CoV-2 Infections in the Community Show Fast Within-Host Change but Little Late Transmission
Oxford’s Prof Katrina Lythgoe and Mahan Ghafari, DPhil, report ONS-CIS data on 576 persistent UK infections with rapid within-host evolution and rare transmission after one month.
www.contagionlive.com
September 11, 2025 at 1:20 PM
Reposted by Susan Hopkins
This week's rapid communications describe

➡️A strain of Neisseria gonorrhoeae producing false negative results on Xpert CT/NG assay in England

🔎An atypical sixfold rise in #influenza A(H1N1)pdm09 cases in Denmark during summer

Full issue here 👉 bit.ly/eus2036

#EpiSky #IDSky #MedSky #STISky 🛟🦠🧫⚕️
September 11, 2025 at 8:41 PM
Reposted by Susan Hopkins
Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South Africa

✅ Just Accepted
#IDSky
Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South Africa
South Africa faces emerging resistance to TB drugs like bedaquiline. Phenotypic drug susceptibility testing (DST), the current reference standard for bedaquiline DST, has long turnaround times.
bit.ly
September 10, 2025 at 3:46 PM
Reposted by Susan Hopkins
In a randomized, controlled trial, persons with early syphilis received a single treatment or three treatments with benzathine penicillin G at a dose of 2.4 million units. No benefit was seen with the additional doses. Full trial results: nej.md/3UVCKVZ

#MedSky #IDSky
September 3, 2025 at 9:10 PM
Reposted by Susan Hopkins
A good story to uplift the start of your week. Read how Botswana eliminated mother to child transmission of HIV. Concerted prioritization of the problem, funding of programs, treatment, and community engagement. In 2023 fewer than 100 kids were born w HIV! 👏🏼 BRAVO.
www.nature.com/articles/d44...
How Botswana eliminated paediatric HIV
Political will, free maternity care and digital health tools helped Botswana achieve high standards for ending mother-to-child transmission.
www.nature.com
August 25, 2025 at 11:56 AM
Reposted by Susan Hopkins
Some great comments -- both pro and con -- have come in response to this post about screening for anal cancer in PWH. Would welcome further opinion, especially from clinicians seeing patients regularly and/or experts in cancer screening. blogs.jwatch.org/hiv-id-obser...
Anal Cancer Screening in HIV: When Guidelines Get Ahead of the Evidence
Should every person with HIV over age 35 (if MSM or transgender woman) or 45 (everyone else) have an anal Pap smear, a digital anal rectal exam (DARE), and possibly a high-resolution anoscopy every 1–...
blogs.jwatch.org
August 25, 2025 at 1:20 PM
Reposted by Susan Hopkins
Just for fun, we resemble these remarks…

(also it seems like the inservice exam exposure histories are lifted from this skit 😂)

#IDSky

youtu.be/t0VFAyAtNdA?...
Infectious Disease Rounds
YouTube video by Dr. Glaucomflecken
youtu.be
August 6, 2025 at 5:04 PM
Reposted by Susan Hopkins
🎶 Straight from the Lab to the Mic: when a Pasteur scientist turns her thesis into a rap 🎶
#FeteDeLaMusique
June 21, 2025 at 3:24 PM
Reposted by Susan Hopkins
New review article

Identifying genomic surveillance gaps in Africa for the global public health response to #WestNileVirus: a systematic review

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #OpenAccess #OA
July 25, 2025 at 7:17 AM
Reposted by Susan Hopkins
In Spain, HCV prevalence in PWH dropped from 60.8% to 27.4% (2002-2023). Active infections fell from 46.3% to 0.9%. Treatment rose from 23% to 99%. Cirrhosis among SVR cases was 20.4% in 2023. 📉🦠##idsky
Trends in HCV Infection Prevalence Among People with HIV in Spain Over Two Decades (2002-2023)
Hepatitis C virus (HCV) has significantly impacted people with HIV (PWH). Harm reduction programs, changing transmission patterns, and direct-acting antivirals (DAAs) have profoundly altered HIV/HCV coinfection trends. This study evaluates HCV prevalence in Spain over two decades.MethodsWe conducted nine cross-sectional studies (2002–2023) in 39–43 centers. Sampled individuals were randomly sampled from PWH actively followed at these centers, with proportional allocation. Main outcomes included anti-HCV antibody and active HCV infection (HCV-RNA+) prevalences.ResultsThe reference population ranged from 31,800 to 47,006, with sample sizes of 1,260–1,867. HIV transmission patterns shifted from 2002 to 2023, with injection drug use (IDU) decreasing from 55% to 21% and men who have sex with men (MSM) increasing from 17% to 46%. HCV seroprevalence fell from 60.8% to 27.4%, and active infection from 46.3% to 0.9%. In the DAA era (2015–2023), active HCV dropped by 100% in heterosexuals, 94% in IDU, and 71% in MSM. Treatment uptake increased from 23% in 2002 to 99% by 2023 with all-oral DAAs. Cirrhosis among active HCV cases peaked at 23.1% in 2015 but fell to 0% by 2021. Among those achieving sustained virologic response (SVR), cirrhosis prevalence was 20.4% in 2023.ConclusionsHIV/HCV coinfection has drastically declined in Spain, with active HCV infection prevalence below 1% since 2021. DAAs were pivotal in this achievement. However, cirrhosis remains a concern among those with SVR. Ongoing surveillance and prevention efforts are essential to sustain these gains and address residual risks.
academic.oup.com
July 25, 2025 at 11:30 AM
Reposted by Susan Hopkins
A new study of over 1.2 million children in Denmark shows no link between aluminum-containing vaccines and autism, asthma, or other health conditions. #IDsky #MEDsky

Stay tuned for our interview on this coming soon: www.contagionlive.com/view/danish-...
Danish Study Reinforces Safety of Childhood Vaccines with Aluminum Adjuvants
New research finds no link between aluminum in vaccines and autism, asthma, or other health conditions, strengthening the case for vaccine safety.
www.contagionlive.com
July 16, 2025 at 7:35 PM
Reposted by Susan Hopkins
"What’s it like to have lived through both HIV and COVID as an ID doctor?"

A new intern asked me that last week.

I didn’t answer it fully then -- but I did here. #IDSky blogs.jwatch.org/hiv-id-obser...
Two Pandemics, Compared: Reflections on HIV and COVID-19
“Dr. Sax, what’s it like to have lived through two pandemics as an ID doctor?” The question came from a brand-new intern during afternoon sign-out. I took a breath — because wow, were they different. ...
blogs.jwatch.org
July 7, 2025 at 5:57 PM
Wow! Much higher than I would have predicted given already washed! I wonder how much more another washing at home removes? Another one for history taking! #idsky
June 23, 2025 at 6:49 AM
Reposted by Susan Hopkins
Lassa fever in rural Guinea shows 82.3% IgG seroprevalence in 1,306 participants. IgM prevalence is 1.8%. High seroprevalence indicates LASV is widespread, often asymptomatic. 🦠📊##idsky
Serosurveillance identifies an endemic hotspot of Lassa fever in Faranah, Upper Guinea
Lassa fever, caused by Lassa virus (LASV), is a rodent-borne disease endemic to West Africa. Despite growing interest from the global health community, the overall disease burden remains poorly understood due to persistent underreporting and inadequate diagnostic capacities. This study aimed to assess LASV infection dynamics in rural Guinea, addressing gaps in understanding its epidemiology in endemic settings.MethodsA cross-sectional serosurveillance study was conducted across six villages in Faranah, Guinea, involving 1,306 participants. Serum samples were analyzed for LASV-specific antibodies using ELISA, and a subset confirmed via immunofluorescence and neutralization assays. Statistical and mathematical models were used to estimate key epidemiological parameters, including the force of infection, antibody waning rates, and infection prevalence.ResultsOverall, IgG seroprevalence was 82.3%, while IgM prevalence stood at 1.8%. Seroprevalence exceeded 50% by age five and increased steadily with age, indicating lifelong exposure. Antibody waning rates suggested an average IgG persistence of 58 years. Mathematical analysis showed that halving LASV prevalence would require a tenfold reduction in the force of spillover, highlighting the challenges of effective control measures.ConclusionsThe seroprevalence observed in this study was markedly higher than reported elsewhere in West Africa, identifying Faranah as a hotspot for LASV transmission. Despite the high seroprevalence and estimated force of infection, the number of reported acute cases is very low, suggesting that LASV may frequently cause pauci- or asymptomatic infections or be commonly misdiagnosed for other diseases. These findings underscore that LASV is more widespread than assumed in rural Guinea.
academic.oup.com
June 13, 2025 at 11:00 AM
Reposted by Susan Hopkins
NEW PRE-PRINT (currently going through peer review)

In this secondary analysis of the RIFASHORT trial we classified TB disease severity at baseline and show that for the majority of people 4-months of rifampicin-based treatment, without the use of a quinolone, was non-inferior to the 6-month SOC.
Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratification
Introduction Recent trials have demonstrated that shortened four-month treatment durations are effective for the majority of people with tuberculosis (TB). However, there is a population of TB patient...
doi.org
June 13, 2025 at 8:19 AM
Reposted by Susan Hopkins
And here’s the write-up with early findings and conclusions.

Phenomenal work!

(Note, all sequencing, analyses, response, etc. done locally!)

virological.org/t/genomic-ep...
May 28, 2025 at 2:43 PM
www.england.nhs.uk/2025/05/nhs-...

Delighted that @ukhsa.bsky.social has played a pivotal role in developing and synthesising evidence to support the national vaccination programmes for gonorrhoea and mpox. This is in addition to hepatitis A and B and HPV. 1/2
NHS England » NHS and local government to roll out world-first vaccine programme to prevent gonorrhoea
Thousands of gonorrhoea cases could be prevented over the next decade thanks to the NHS’ world-first vaccination programme against the infection. Eligible patients, which includes gay and bisexual men...
www.england.nhs.uk
May 21, 2025 at 6:03 PM
Great to see this in print. Complex public health ethical decision making framework. @ukhsa.bsky.social
How do you balance public health risk with individual rights? Here’s how we tried to do it in a complex XDR-TB case, great collaborative effort!

academic.oup.com/jpubhealth/a...
A decision-making model for public health authorities in circumstances of potentially high public risk
academic.oup.com
May 19, 2025 at 12:33 PM
Reposted by Susan Hopkins
A podcast release yesterday from EID (long time coming)!

"Homelessness and #Bartonella quintana Infections" #idsky

Interesting lineup of articles for discussion on an underrecognized issue.

wwwnc.cdc.gov/eid/podcasts
Podcasts Volume 30 - Emerging Infectious Diseases journal - CDCCenters for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting Peoplehome4expandexpandexpandexpandexpandexpa...
Scientific podcasts based on current articles from Emerging Infectious Diseases journal. Listen and learn about emerging infectious disease research from leading scientists.
wwwnc.cdc.gov
May 17, 2025 at 2:31 PM
Reposted by Susan Hopkins
A case-cluster of aseptic meningitis associated with a newly identified recombinant echovirus6/CoxsackievirusB1 enterovirus

✅ Just Accepted
#IDSky
A case-cluster of aseptic meningitis associated with a newly identified recombinant echovirus6/CoxsackievirusB1 enterovirus
A daycare teacher presented with complaints of headache, neck stiffness, and fever. Because of initial concerns about meningococcal meningitis, families of daycare attendees were notified and 10 children from the daycare presented for evaluation.
doi.org
May 17, 2025 at 2:44 PM